These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 18991755)

  • 1. Antioxidant therapy in Alzheimer's disease: theory and practice.
    Aliev G; Obrenovich ME; Reddy VP; Shenk JC; Moreira PI; Nunomura A; Zhu X; Smith MA; Perry G
    Mini Rev Med Chem; 2008 Nov; 8(13):1395-406. PubMed ID: 18991755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of nanoyttria in alleviating oxidative stress biomarkers: Implications for Alzheimer's disease therapy.
    Tang KS
    Life Sci; 2020 Oct; 259():118287. PubMed ID: 32814066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.
    Prasad KN; Bondy SC
    Curr Aging Sci; 2014; 7(2):77-90. PubMed ID: 25101711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.
    Walia V; Kaushik D; Mittal V; Kumar K; Verma R; Parashar J; Akter R; Rahman MH; Bhatia S; Al-Harrasi A; Karthika C; Bhattacharya T; Chopra H; Ashraf GM
    Mol Neurobiol; 2022 Jan; 59(1):657-680. PubMed ID: 34751889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Free Radicals in Oxidative Stress-Related Human Diseases.
    Poprac P; Jomova K; Simunkova M; Kollar V; Rhodes CJ; Valko M
    Trends Pharmacol Sci; 2017 Jul; 38(7):592-607. PubMed ID: 28551354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant treatment in Alzheimer's disease: current state.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Mol Neurosci; 2003; 21(1):1-11. PubMed ID: 14500988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype.
    Ramassamy C; Averill D; Beffert U; Bastianetto S; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Davignon J; Quirion R; Poirier J
    Free Radic Biol Med; 1999 Sep; 27(5-6):544-53. PubMed ID: 10490274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis.
    Teixeira JP; de Castro AA; Soares FV; da Cunha EFF; Ramalho TC
    Molecules; 2019 Dec; 24(23):. PubMed ID: 31816853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant pathways in Alzheimer's disease: possibilities of intervention.
    Viña J; Lloret A; Giraldo E; Badia MC; Alonso MD
    Curr Pharm Des; 2011 Dec; 17(35):3861-4. PubMed ID: 21933145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease.
    Moneim AE
    Curr Alzheimer Res; 2015; 12(4):335-49. PubMed ID: 25817254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential alterations in antioxidant capacity in cells from Alzheimer patients.
    Gibson GE; Zhang H; Sheu KR; Park LC
    Biochim Biophys Acta; 2000 Nov; 1502(3):319-29. PubMed ID: 11068175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corydalis edulis total alkaloids (CETA) ameliorates cognitive dysfunction in rat model of Alzheimer disease through regulation of the antioxidant stress and MAP2/NF-κB.
    Liang S; Zheng Y; Lei L; Deng X; Ai J; Li Y; Zhang T; Mei Z; Ren Y
    J Ethnopharmacol; 2020 Apr; 251():112540. PubMed ID: 31917278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?
    Persson T; Popescu BO; Cedazo-Minguez A
    Oxid Med Cell Longev; 2014; 2014():427318. PubMed ID: 24669288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?
    Moreira PI; Smith MA; Zhu X; Honda K; Lee HG; Aliev G; Perry G
    Drug News Perspect; 2005; 18(1):13-9. PubMed ID: 15753972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of reactive oxygen species in the progression of Alzheimer's disease.
    Bhatt S; Puli L; Patil CR
    Drug Discov Today; 2021 Mar; 26(3):794-803. PubMed ID: 33306995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunopathogenic role of reactive oxygen species in Alzheimer disease.
    Mohsenzadegan M; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2012 Sep; 11(3):203-16. PubMed ID: 22947905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease.
    Hasan I; Guo B; Zhang J; Chang C
    Antioxid Redox Signal; 2024 May; 40(13-15):863-888. PubMed ID: 36070437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.